CMPX
Compass Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.38
+0.42%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.12
- Revenue estimate
- $229.3K
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.13
- EPS estimate
- -$0.11
- Revenue actual
- —
- Revenue estimate
- -$600.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +7.4%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026